Editorial methodology
What stage is this evidence at?
Every piece of Fronteira Regenerativa content answers this question. Below are the seven stages we use — from established clinical use to hypothesis — and what each one does, or does not, allow us to claim.
- 01
What does “Established clinical use” mean?
A practice incorporated into routine care for a specific indication, supported by consistent clinical evidence, regulatory backing and recognition in official guidelines or protocols.
Recognition applies to that indication and that setting — it does not automatically extend to other diseases or to other technologies in the same class.
- 03
What does “Clinical trial” mean?
Research conducted in humans, under a protocol approved by an ethics committee and, where applicable, by the health authority, to assess the safety and efficacy of an intervention in successive phases (I, II and III).
Being in a clinical trial means the question is being tested — not that the answer already exists. Ethics approval is not marketing authorization.
- 04
What does “Investigational” mean?
An intervention not yet authorized for the indication in question, available only within formal research or specific regulatory pathways, with preliminary or incomplete data.
Early results may be promising, but they do not yet establish clinical benefit in routine use.
- 05
What does “Preclinical” mean?
Evidence obtained in the laboratory — cell cultures, tissues or animal models — before any testing in humans.
A good result in an animal model shows that investigation in people is worthwhile, not that the effect will be reproduced in them.
- 06
What does “Biological rationale” mean?
A theoretical basis, grounded in known biological mechanisms, that makes an intervention plausible before there is direct experimental demonstration of the intended effect.
Biological plausibility is not clinical efficacy: many promising mechanisms are not confirmed in practice.
- 07
What does “Hypothesis / outlook” mean?
An idea, projection or future direction of science not yet supported by data. It serves to guide research and debate, not clinical decisions.
Outlooks help us understand where the field may be heading — and must be presented as such.
Classification must be made by product, indication, regulatory context and timing of the evidence. Results for one technology do not automatically validate the whole class.
